Red cell exchange removes apixaban in patients with sickle cell disease.

Saved in:
Bibliographic Details
Title: Red cell exchange removes apixaban in patients with sickle cell disease.
Authors: Boyle K; Division of Hematology, Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA., Evans M; Department of Apheresis, Duke University Medical Center, Durham, North Carolina, USA., Mansfield C; Department of Perioperative Services, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA., Notini M; Clinical Coagulation, Duke University Hospital Laboratories, Durham, North Carolina, USA., Garrett ME; Duke Molecular Physiology Institute, Duke University Medical Center, Durham, North Carolina, USA., Arepally GM; Division of Hematology, Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA., Lee GM; Division of Hematology, Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.
Source: Transfusion [Transfusion] 2026 Jul; Vol. 66 (7), pp. 1252-1256. Date of Electronic Publication: 2026 May 07.
Publication Type: Journal Article
Journal Info: Publisher: American Association Of Blood Banks Country of Publication: United States NLM ID: 0417360 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1537-2995 (Electronic) Linking ISSN: 00411132 NLM ISO Abbreviation: Transfusion Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1537-2995
DOI:10.1111/trf.70257